Your browser doesn't support javascript.
loading
Weekly versus Three-Weekly Cisplatin-based Concurrent Chemoradiotherapy as definitive treatment in Head and Neck Cancer- Where do we stand?
Rawat, S; Srivastava, H; Ahlawat, P; Pal, M; Gupta, G; Chauhan, D; Tandon, S; Khurana, R.
Affiliation
  • Rawat S; Department of Radiation Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.
  • Srivastava H; Department of Radiation Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.
  • Ahlawat P; Department of Radiation Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.
  • Pal M; Department of Radiation Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.
  • Gupta G; Department of Radiation Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.
  • Chauhan D; Department of Radiation Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.
  • Tandon S; Department of Radiation Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.
  • Khurana R; Department of Radiation Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.
Gulf J Oncolog ; 1(21): 6-11, 2016 May.
Article in En | MEDLINE | ID: mdl-27250881
Subject(s)
Key words
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Antineoplastic Combined Chemotherapy Protocols / Cisplatin / Chemoradiotherapy / Head and Neck Neoplasms / Antineoplastic Agents Type of study: Clinical_trials Limits: Humans Language: En Journal: Gulf J Oncolog Journal subject: NEOPLASIAS Year: 2016 Document type: Article Affiliation country: Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Antineoplastic Combined Chemotherapy Protocols / Cisplatin / Chemoradiotherapy / Head and Neck Neoplasms / Antineoplastic Agents Type of study: Clinical_trials Limits: Humans Language: En Journal: Gulf J Oncolog Journal subject: NEOPLASIAS Year: 2016 Document type: Article Affiliation country: Country of publication: